Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
Clinical trial NCT01363232 · COMPLETED
Trial details
- NCT number
- NCT01363232
- Sponsor
- Array Biopharma, now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2014-03-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.